Koninklijke Philips reported EUR9.33B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Abbott USD 23.5B 1.02B Sep/2026
Baxter International USD 6.83B 163M Sep/2026
Becton, Dickinson and Co. USD 8.32B 178M Sep/2026
Boston Scientific USD 8.16B 192M Sep/2026
Danaher USD 14.79B 1.41B Sep/2026
Demant DKK 10.2B 130M Jun/2026
Dexcom USD 3.92B 170.6M Sep/2026
Edwards Lifesciences USD 7.25B 428.6M Sep/2026
Fresenius EUR 12.29B 678M Sep/2026
General Electric Aerospace USD 41.53B 1.83B Sep/2026
Getinge SEK 15.77B 2.39B Jun/2026
Globus Medical USD 2.18B 33.55M Sep/2026
GN Store Nord DKK 20.15B 14.52B Sep/2026
Hitachi JPY 8.28T 444.27B Sep/2026
Idexx Laboratories USD 1.5B 9.48M Sep/2026
Insulet USD 2.04B 192.4M Sep/2026
Integra LifeSciences USD 1.19B 1.54M Sep/2026
Intuitive Surgical USD 10.65B 1.68B Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Koninklijke Philips EUR 9.33B 454M Jun/2026
Medtronic USD 24.39B 397M Jun/2026
Philips EUR 10.51B 1.18B Sep/2026
ResMed USD 3.51B 815.82M Sep/2026
Smith & Nephew USD 4.39B 240M Jun/2026
Steris USD 2.48B 33.4M Sep/2026
Stryker USD 14.18B 235M Sep/2026
Teleflex USD 1.84B 31.2M Sep/2026
Terumo JPY 877.74B 28.86B Sep/2026
Zimmer Biomet Holdings USD 5.13B 32.3M Sep/2026